U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 42

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:1807549
GRCh38:
Chr4:1805822
FGFR3P461L, P573L, P574L, P575LGerm cell tumor of testis, Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Epidermal nevus, Cervix cancer,
Thanatophoric dysplasia, type 2, Hypochondroplasia, Colorectal cancer,
Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndromeThanatophoric dysplasia type 1,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome, not provided,
...see more
Uncertain significance
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr4:1801055
GRCh38:
Chr4:1799328
FGFR3P62SFGFR3-related disoder, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Cervix cancer, Thanatophoric dysplasia, type 2, Hypochondroplasia,
Colorectal cancer, AchondroplasiaCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
...see more
Uncertain significance
(Feb 1, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr4:1807915
GRCh38:
Chr4:1806188
FGFR3not provided, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Cervix cancer, Thanatophoric dysplasia, type 2, Hypochondroplasia,
Colorectal cancer, AchondroplasiaCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
...see more
Benign/Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:1807887
GRCh38:
Chr4:1806160
FGFR3K537R, K649R, K650R, K651Rnot provided, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Cervix cancer, Thanatophoric dysplasia, type 2, Hypochondroplasia,
Colorectal cancer, AchondroplasiaCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
...see more
Uncertain significance
(Jan 17, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr4:1807658
GRCh38:
Chr4:1805931
FGFR3not provided, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Cervix cancer, Thanatophoric dysplasia, type 2, Hypochondroplasia,
Colorectal cancer, AchondroplasiaCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Connective tissue disorder, ...see more
Conflicting interpretations of pathogenicity
(Apr 14, 2022)
criteria provided, conflicting interpretations
6.
GRCh37:
Chr4:1806551
GRCh38:
Chr4:1804824
FGFR3V311L, V423L, V424L, V425Lnot provided, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Muenke syndrome, Epidermal nevus,
Cervix cancer, Thanatophoric dysplasia, type 2, Hypochondroplasia,
Colorectal cancer, AchondroplasiaCamptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Inborn genetic diseases, ...see more
Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr4:1806164
GRCh38:
Chr4:1804437
FGFR3L395I, L397IAchondroplasiaLikely pathogenic
(May 9, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr4:1806125
GRCh38:
Chr4:1804398
FGFR3G382S, G384SAchondroplasiaLikely pathogeniccriteria provided, single submitter
9.
FBN1AchondroplasiaLikely pathogeniccriteria provided, single submitter
10.
GRCh37:
Chr4:1807298
GRCh38:
Chr4:1805571
FGFR3D404G, D516G, D517G, D518GAchondroplasia, Cervix cancer, Levy-Hollister syndrome,
Muenke syndrome, Hypochondroplasia, Epidermal nevus,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Crouzon syndrome-acanthosis nigricans syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testisMalignant tumor of urinary bladder,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer, not provided,
...see more
Uncertain significance
(Jan 5, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr4:1806236
GRCh38:
Chr4:1804509
FGFR3L419F, L421FAchondroplasia, Cervix cancer, Levy-Hollister syndrome,
Muenke syndrome, Hypochondroplasia, Epidermal nevus,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Crouzon syndrome-acanthosis nigricans syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testisMalignant tumor of urinary bladder,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Colorectal cancer, not provided,
...see more
Uncertain significance
(Jul 20, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr4:1807357
GRCh38:
Chr4:1805630
FGFR3K424E, K536E, K537E, K538EAchondroplasiaUncertain significance
(Nov 29, 2019)
criteria provided, single submitter
13.
GRCh37:
Chr4:1805477
GRCh38:
Chr4:1803750
FGFR3T330Inot provided, AchondroplasiaUncertain significance
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr15:48812873
GRCh38:
Chr15:48520676
LOC113939944, FBN1C377YFamilial thoracic aortic aneurysm and aortic dissection, Marfan syndrome, Achondroplasia,
Marfan syndrome
Likely pathogenic
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr4:1808981
GRCh38:
Chr4:1807254
FGFR3A782V, R807W, R693W, R805W, R806WAchondroplasia, Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Levy-Hollister syndrome, Muenke syndrome, Malignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Epidermal nevus, Colorectal cancerThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Germ cell tumor of testis, not provided,
...see more
Uncertain significance
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr4:1806615
GRCh38:
Chr4:1804888
FGFR3S444F, S446F, S332F, S445FInborn genetic diseasesUncertain significance
(Jan 29, 2021)
criteria provided, single submitter
17.
GRCh37:
Chr4:1801071
GRCh38:
Chr4:1799344
FGFR3G67Dnot provided, Achondroplasia, Cervix cancer,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Epidermal nevus, Carcinoma of colon,
Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Thanatophoric dysplasia type 1, Muenke syndromeThanatophoric dysplasia, type 2,
Malignant tumor of urinary bladder, Hypochondroplasia, Malignant tumor of testis,
...see more
Conflicting interpretations of pathogenicity
(May 7, 2022)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr4:1808395
GRCh38:
Chr4:1806668
FGFR3N718S, N720S, N719S, N606SAchondroplasia, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Carcinoma of colon, Malignant tumor of urinary bladder, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Cervix cancer, Levy-Hollister syndrome,
Malignant tumor of testis, Muenke syndromeThanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Epidermal nevus, Inborn genetic diseases,
not provided, ...see more
Uncertain significance
(Jul 9, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr4:1808017
GRCh38:
Chr4:1806290
FGFR3A667S, A665S, A553S, A666SAchondroplasia, Cervix cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Crouzon syndrome-acanthosis nigricans syndrome,
Malignant tumor of urinary bladder, Levy-Hollister syndrome, Epidermal nevus,
Carcinoma of colon, Malignant tumor of testisMuenke syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, not provided,
...see more
Uncertain significance
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr4:1807977
GRCh38:
Chr4:1806250
FGFR3Achondroplasia, Cervix cancer, Germ cell tumor of testis,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Hypochondroplasia, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Malignant tumor of urinary bladder, Levy-Hollister syndrome,
Epidermal nevus, Colorectal cancerMuenke syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, not provided,
...see more
Benign/Likely benign
(Feb 15, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr4:1807371
Chr4:1807123
GRCh38:
Chr4:1805644
Chr4:1805396
FGFR3, FGFR3N540K, N542K, N428K, N541K, Q485R, Q487R, Q373R, Q486RThanatophoric dysplasia type 1Pathogenic
(Jun 1, 2009)
no assertion criteria provided
22.
GRCh37:
Chr4:1806119
Chr4:1806111
GRCh38:
Chr4:1804392
Chr4:1804384
FGFR3, FGFR3G380R, G382R, L377R, L379RAchondroplasiaPathogenic
(Feb 1, 2006)
no assertion criteria provided
23.
GRCh37:
Chr4:1803341
GRCh38:
Chr4:1801614
FGFR3not provided, not specified, Achondroplasia
Conflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr4:1801219
GRCh38:
Chr4:1799492
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Cervix cancer, Levy-Hollister syndrome,
Malignant tumor of urinary bladder, Hypochondroplasia, Germ cell tumor of testis,
Epidermal nevus, Colorectal cancerCrouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Connective tissue disorder,
not provided, not specified, ...see more
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr4:1806131
GRCh38:
Chr4:1804404
FGFR3F384L, F386LAchondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cervix cancer,
Muenke syndrome, Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2,
Hypochondroplasia, Germ cell tumor of testis, Malignant tumor of urinary bladder,
Epidermal nevus, Severe achondroplasia-developmental delay-acanthosis nigricans syndromeColorectal cancer,
Crouzon syndrome-acanthosis nigricans syndrome, Levy-Hollister syndrome, Connective tissue disorder,
not specified, not provided, Hypochondroplasia,
...see more
Benign/Likely benign
(Dec 1, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr4:1807876
GRCh38:
Chr4:1806149
FGFR3Achondroplasia, Levy-Hollister syndrome, Germ cell tumor of testis,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Cervix cancer, Crouzon syndrome-acanthosis nigricans syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of urinary bladder, Epidermal nevusColorectal cancer,
Muenke syndrome, Hypochondroplasia, not provided,
...see more
Benign/Likely benign
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650T, K652T, K538T, K651TFGFR3-related disorder, Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, Epidermal nevus,
Cervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Malignant tumor of urinary bladder, HypochondroplasiaCrouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Malignant tumor of testis, Carcinoma of colon,
not provided, ...see more
Pathogenic
(Jul 25, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr4:1808988
GRCh38:
Chr4:1807261
FGFR3Achondroplasia, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Epidermal nevus, Colorectal cancer,
Cervix cancer, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Levy-Hollister syndrome,
Malignant tumor of urinary bladder, HypochondroplasiaCrouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Germ cell tumor of testis, not provided,
...see more
Pathogenic
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr4:1801122
GRCh38:
Chr4:1799395
FGFR3S84LAchondroplasia, Hypochondroplasia, Levy-Hollister syndrome,
Crouzon syndrome-acanthosis nigricans syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Thanatophoric dysplasia type 1,
Thanatophoric dysplasia, type 2, Muenke syndrome, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
not provided, Achondroplasia ...see more
Pathogenic/Likely pathogenic
(May 4, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr4:1803657
GRCh38:
Chr4:1801930
FGFR3S279Cnot provided, AchondroplasiaPathogenic/Likely pathogenic
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr4:1807370
GRCh38:
Chr4:1805643
FGFR3N540S, N542S, N541S, N428SInborn genetic diseases, not provided, Hypochondroplasia,
Achondroplasia, Neurodevelopmental delay
Conflicting interpretations of pathogenicity
(Feb 23, 2023)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr4:1807891
GRCh38:
Chr4:1806164
FGFR3K650N, K652N, K651N, K538NColorectal cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Cervix cancer, Achondroplasia, Thanatophoric dysplasia, type 2,
Muenke syndrome, Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Epidermal nevus, Malignant tumor of urinary bladderCrouzon syndrome-acanthosis nigricans syndrome,
Hypochondroplasia, Thanatophoric dysplasia type 1, not provided,
Hypochondroplasia, ...see more
Pathogenic/Likely pathogenic
(Mar 17, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr4:1807890
GRCh38:
Chr4:1806163
FGFR3K650M, K652M, K538M, K651MColorectal cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Cervix cancer, Achondroplasia, Thanatophoric dysplasia, type 2,
Muenke syndrome, Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Epidermal nevus, Malignant tumor of urinary bladderCrouzon syndrome-acanthosis nigricans syndrome,
Hypochondroplasia, Thanatophoric dysplasia type 1, not provided,
Hypochondroplasia, ...see more
Pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr4:1803571
GRCh38:
Chr4:1801844
FGFR3P250RSeizure, Unilateral renal agenesis, Facial asymmetry,
Craniofacial dysostosis, Infantile axial hypotonia, Coronal craniosynostosis,
Generalized non-motor (absence) seizure, Inborn genetic diseases, FGFR3-related chondrodysplasia,
Colorectal cancer, Camptodactyly-tall stature-scoliosis-hearing loss syndromeLevy-Hollister syndrome,
Cervix cancer, Achondroplasia, Thanatophoric dysplasia, type 2,
Muenke syndrome, Germ cell tumor of testis, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Epidermal nevus, Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome,
Hypochondroplasia, Thanatophoric dysplasia type 1, Craniosynostosis syndrome,
not provided, Hypochondroplasia, Muenke syndrome,
Achondroplasia, Abnormality of the nervous system, ...see more
Pathogenic/Likely pathogenic
(Mar 21, 2023)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr4:1803568
GRCh38:
Chr4:1801841
FGFR3S249CConnective tissue disorder, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Cervix cancer, Achondroplasia, Carcinoma of colon,
Thanatophoric dysplasia, type 2, Muenke syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Epidermal nevusMalignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia, Thanatophoric dysplasia type 1,
not provided, Cervix cancer, Malignant tumor of urinary bladder,
Thanatophoric dysplasia type 1, ...see more
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N541K, N428KConnective tissue disorder, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Cervix cancer, Achondroplasia, Carcinoma of colon,
Thanatophoric dysplasia, type 2, Muenke syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Epidermal nevusMalignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia, Thanatophoric dysplasia type 1,
Inborn genetic diseases, not provided, Larsen syndrome,
Hypochondroplasia, Achondroplasia, Short stature,
...see more
Pathogenic/Likely pathogenic
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr4:1807371
GRCh38:
Chr4:1805644
FGFR3N540K, N542K, N428K, N541Knot provided, Hypochondroplasia, Achondroplasia,
Neurodevelopmental delay
Pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr4:1808987
GRCh38:
Chr4:1807260
FGFR3V784EAchondroplasia, Epidermal nevus, Crouzon syndrome-acanthosis nigricans syndrome,
Muenke syndrome, Levy-Hollister syndrome, Germ cell tumor of testis,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Hypochondroplasia, Malignant tumor of urinary bladder,
Colorectal cancer, Cervix cancerSevere achondroplasia-developmental delay-acanthosis nigricans syndrome,
Thanatophoric dysplasia type 1, Thanatophoric dysplasia, type 2, not provided,
...see more
Pathogenic
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr4:1803564
GRCh38:
Chr4:1801837
FGFR3R248CFGFR3-related disorder, Connective tissue disorder, Camptodactyly-tall stature-scoliosis-hearing loss syndrome,
Levy-Hollister syndrome, Cervix cancer, Achondroplasia,
Carcinoma of colon, Thanatophoric dysplasia, type 2, Muenke syndrome,
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome, Malignant tumor of testisEpidermal nevus,
Malignant tumor of urinary bladder, Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia,
Thanatophoric dysplasia type 1, FGFR3-related chondrodysplasia, not provided,
Cervix cancer, Thanatophoric dysplasia type 1, Achondroplasia,
Hamartoma, Small for gestational age, Bell-shaped thorax,
Short stature, Short ribs, Narrow chest,
Skeletal dysplasia, Disproportionate short-limb short stature, Lethal short-limbed short stature,
Growth delay, Lower limb undergrowth, Bowed humerus,
Femoral bowing, Upper limb undergrowth, ...see more
Pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr4:1806104
GRCh38:
Chr4:1804377
FGFR3G375C, G377Cnot providedPathogenic
(Feb 24, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382Rnot provided, Hypochondroplasia, Achondroplasia
Pathogenic
(Dec 15, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr4:1806119
GRCh38:
Chr4:1804392
FGFR3G380R, G382RConnective tissue disorder, Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Levy-Hollister syndrome,
Cervix cancer, Achondroplasia, Carcinoma of colon,
Thanatophoric dysplasia, type 2, Muenke syndrome, Severe achondroplasia-developmental delay-acanthosis nigricans syndrome,
Malignant tumor of testis, Epidermal nevusMalignant tumor of urinary bladder,
Crouzon syndrome-acanthosis nigricans syndrome, Hypochondroplasia, Thanatophoric dysplasia type 1,
Inborn genetic diseases, not specified, not provided,
Camptodactyly-tall stature-scoliosis-hearing loss syndrome, Hypochondroplasia, Achondroplasia,
...see more
Pathogenic
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination